Journal Home
Search for

Volume 15, Issue 1, Pages 116-120 (January 2005)


View previous. 23 of 41 View next.

Leptin, adiponectin, and ghrelin dysregulation in chronic kidney disease

Fitsum Guebre-Egziabher, MD*, Jacques Bernhard, MD*, Ghislaine Geelen, PhD, Etienne Malvoisin, PhD§, Aoumeur Hadj-Aissa, MD, Denis Fouque, MD, PhD*Corresponding Author Informationemail address

In the past 10 years, 3 new metabolic compounds, leptin, adiponectin, and ghrelin, involved in energy metabolism, body composition, and appetite regulation, have been discovered. We have assessed their characteristics in 46 patients with stage 3 to 4 chronic kidney disease to evaluate the role of decreased renal function in the abnormal handling reported in more severe end-stage renal disease patients. In addition to the usual correlations with body mass index and body fat mass, the results show unexpected positive correlations between leptin and insulin, leptin and adiponectin, a weak inverse relationship between adiponectin and glomerular filtration rate, and no influence of C-reactive protein on either leptin or adiponectin in these noninflamed patients. Serum ghrelin was inversely correlated with body mass index and with glomerular filtration rate as measured by inulin clearance. Thus, ghrelin and leptin, 2 antagonist signals for energy balance, both seem to increase when glomerular filtration rate is reduced, potentially neutralizing their respective biologic effects in severe renal insufficiency.

* Département de Néphrologie, Hôpital E. Herriot, Lyon, France.

 Unité de Recherche JE 2411- Université Claude Bernard, Lyon, France.

 Laboratoire d’Explorations Fonctionnelles Rénales et Métaboliques, Hôpital E. Herriot, Lyon, France.

§ Laboratoire de Radioimmunoanalyse, Hôpital Edouard Herriot, Lyon, France.

Corresponding Author InformationAddress reprint requests to Denis Fouque, MD, Department of Nephrology, Hôpital E. Herriot, 69437 Lyon Cedex 03, France.

 Supported in part by the University Claude Bernard, Lyon.

PII: S1051-2276(04)00172-4

doi:10.1053/j.jrn.2004.09.015


View previous. 23 of 41 View next.